FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach
Emily Daugherty(Cincinnati Children's Hospital Medical Center), John P. Perentesis(University of Southern California), Claire McCann(Siemens Healthcare (United States)), JD Bradley(University of Pennsylvania), Deepak Khuntia(Mills Peninsula Health Services), Mathieu Sertorio(University of Cincinnati Medical Center), Anthony Mascia(Cincinnati Children's Hospital Medical Center), Ram A. Sharma(Siemens Healthcare (United States)), Ye Zhang(University of Shanghai for Science and Technology), Zhiyan Xiao(Cincinnati Children's Hospital Medical Center), K. Russell(Siemens Healthcare (United States)), Jennifer M. P. Woo(Siemens Healthcare (United States)), J Breneman(University of Cincinnati), C.B. Simone(New York Proton Center)
Cited by 90
Related Papers
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial
|Neuro-Oncology|2013|942
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001
|Journal of Clinical Oncology|2020|827
Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases
|JAMA Oncology|2022|557
Renal Carcinomas With the t(6;11)(p21;q12)
|The American Journal of Surgical Pathology|2005|290
Management of Metabolic Effects Associated With Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway
|Journal of Clinical Oncology|2012|231